Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma

NCT01876212 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Melanoma

Interventions

BIOLOGICAL: DC vaccine
DRUG: Dasatinib

Sponsor

Walter J. Storkus

Collaborators

[object Object]